Systemic embolism
Multiple systemic embolism in infective endocarditis underlying in Barlow’s disease
... 12 days after presentation, he complained of severe retrosternal chest pain radiating to his back, with ECG showing ST-segment elevation in V3, V4, and V5 leads (Fig. 2a), and increased troponin T (0.542 ng/ml) and CK-MB ...
5
Incidence, type of atrial fibrillation and risk factors for stroke: a population-based cohort study
... The major limitation of our study is the retrospective collection of patient data. The accuracy of our incidence rate and our evaluation of the type of AF depended on the patient having contacted a healthcare provider if ...
10
Nonvalvular atrial fibrillation: a study of epidemiology, demography and clinicoetiological profile in Central India
... and systemic embolism in patients with AF is determined by patient risk ...and systemic embolism in patient with nonvalvular AF are a history of previous stroke of transient ischemic attacks ...
7
Apixaban for the prophylaxis and treatment of deep vein thrombosis and pulmonary embolism: an evidence-based review
... warfarin are used extensively in the prevention and treatment of VTE and prevention of stroke and systemic embolism in patients with atrial fibrillation or mechanical heart valves. Although warfarin has ...
10
Atrial fibrillation and its influence on stroke risk
... demonstrated to perform better than the previous risk strati- fication schemes for the prediction of thromboembolism. Patients with one or more major risk factors (eg, previous stroke, TIA, or systemic ...
5
PHARMACEUTICAL EFFECTIVENESS AND SAFETY OF WARFARIN AND DABIGATRAN IN PATIENTS WITH ATRIAL FIBRILLATION
... Dabigatran was the first direct oral anticoagulant approved for stroke prevention in patients with non- valvular atrial fibrillation (NVAF). The RELY (Randomized Evaluation of Long-term Anticoagulation Therapy) study ...
7
The clinical efficacy of dabigatran etexilate for preventing stroke in atrial fibrillation patients
... and systemic embolism prevention in the setting of specifically non valvular atrial fibrillation (NVAF) has provided clinicians with a realistic treatment alternative to the traditional dose- adjusted, ...
12
Efficacy and safety of non-vitamin K antagonist oral anticoagulants compared with warfarin in patients with atrial fibrillation
... In this large non-selected Swedish atrial fibrillation cohort without previous oral anticoagulation treatment, NOACs were no better than well-managed warfarin for preven- tion of all-cause stroke or systemic ...
9
Who will benefit from anticoagulant therapy? Use of the CHADS<sub>2</sub> score and its variants
... The association of troponin and increased cardiovascu- lar events was evaluated prospectively in a subgroup of the original RE-LY cohort. This substudy included 6,189 AF patients, of whom 55% had detectable troponins. ...
10
Surgical treatment for thoracoabdominal intra aortic thrombus with multiple infarctions: a case report
... further systemic embolism or conversion to extended surgery is possibly quite less compared to that with thrombolytic medication therapy [1, ...with systemic aortic embolism has been recom- ...
5
Clinical utility of apixaban in the prevention and treatment of venous thromboembolism: current evidence
... of systemic embolism in patients with nonvalvular atrial fibrillation with any two of the following conditions – moderate renal impairment (serum creatinine ...
11
Management of patients with atrial fibrillation at high risk of stroke: current treatment options
... or systemic embo- lism (as in ROCKET-AF and ...or systemic embolism, with a similar risk of major hemorrhage, whereas lower dose dabigatran was associated with a similar risk of stroke or ...
13
An authoritative algorithm most appropriate for the prediction of pulmonary embolism in patients with AECOPD
... All eligible patients were collected according to the in- clusion and exclusion criteria. The inclusion criteria comprised: 1) all eligible patients had a confirmed diag- nosis of COPD according to the guidelines [16]; ...
7
Concurrent Massive Pulmonary Embolism and Brachial Artery Embolism in a Genetic Background
... While it is well known that some genetic factors defin- itively increase the risk for arterial or venous throm- bosis, it is still controversial whether or not that risk is augmented by plasminogen activator inhibitor 1 ...
5
Incidence of venous thromboembolism in northern Sweden (VEINS): a population-based study
... pulmonary embolism compared to DVT ...pulmonary embolism in our study, compared to other studies, might be attributable to the different study ...pulmonary embolism in our study was our inclusion of ...
7
Amniotic fluid embolism as a cause of maternal mortality in China between 1996 and 2013: a population based retrospective study
... Amniotic fluid embolism (AFE) is a rare complication of pregnancy with a comparatively high mortality [11]. It often presents as the sudden onset of cardiovascular col- lapse, respiratory compromise and ...
8
Case report of amniotic fluid embolism coagulopathy following abortion; use of viscoelastic point of care analysis
... Case report of amniotic fluid embolism coagulopathy following abortion; use of viscoelastic point of care analysis CASE REPORT Open Access Case report of amniotic fluid embolism coagulopathy following[.] ...
7
Case Report Isolated pulmonary arteriovenous fistula: insights from diagnosing young-onset stroke
... Paradoxical embolism (PE) is one of the main causes of stroke in young patients. Rarely, PE can develop at the pulmonary level, such as in patients with pulmonary arteriovenous fistula (PAVF). As a treatable cause ...
6
Sudden Maternal Deaths Probably Due to Obstetrical Pulmonary Embolism in Malaysia, 1991
... Sudden Maternal Deaths Probably Due to Obstetrical Pulmonary Embolism In Malaysia for 1991 ORIGINAL ARTICLE Sudden Maternal Deaths Probably Due to Obstetrical Pulmonary Embolism In Malaysia for 1991 J[.] ...
9
Pulmonary embolism in non brain tumor patients after surgery—a retrospective study in China
... ACCP 9th Ed.: American College of Chest Physicians, ninth edition; APACHE II score: Acute Physiology and Chronic Health Evaluation II score; AUC: Area under the curve; BMI: Body mass index; BNP: Brain natriuretic ...
6